52293-23-9CS(=O)(=O)O.c1cnc(N2CCN(Cc3ccc4c(c3)OCO4)CC2)nc1DEZKFCIOSKCCHK-UHFFFAOYSA-N52293-23-9DTXSID30200314CHEMBL1468572Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H336 (100%): May cause drowsiness or dizziness [Warning Specific target organ toxicity, single exposure; Narcotic effects]
P203, P260, P261, P263, P264, P270, P271, P273, P304+P340, P318, P319, P403+P233, P405, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.
Drugs that bind to and activate dopamine receptors.